Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Leukemia 33Leukemia, Lymphocytic, Chronic, B-Cell 26Lymphoma 19Myelodysplastic Syndromes 16Hodgkin Disease 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Multiple Myeloma 10Leukemia, Myeloid, Acute 10Lymphoma, Non-Hodgkin 8Lymphoma, Mantle-Cell 7Lymphoma, Follicular 7Recurrence 6Myeloproliferative Disorders 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Chronic-Phase 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hematologic Neoplasms 5Waldenstrom Macroglobulinemia 4Neoplasms, Plasma Cell 4Lymphoma, T-Cell, Cutaneous 4Congenital Abnormalities 4Burkitt Lymphoma 4Anemia, Aplastic 4Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic-Myeloproliferative Diseases 3Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Large-Cell, Immunoblastic 3

Interventions

Cyclophosphamide 13Etoposide 10Prednisone 8Doxorubicin 8Whole-Body Irradiation 7Vincristine 7Rituximab 7Peripheral Blood Stem Cell Transplantation 7Melphalan 7Brentuximab Vedotin 7romidepsin 6fludarabine phosphate 6Mycophenolic Acid 6fludarabine 5Lenalidomide 5Gemcitabine 5Cytarabine 510-propargyl-10-deazaaminopterin 5Tacrolimus 4Granulocyte Colony-Stimulating Factor 4Carmustine 4Busulfan 4Antilymphocyte Serum 4pembrolizumab 3etoposide phosphate 3carmustine, poliferprosan 20 drug combination 3Vorinostat 3Sirolimus 3Nivolumab 3Filgrastim 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Lymphoma, T-Cell × Alemtuzumab × Clear all
NCT00069238 2022-02-24

Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
31 enrolled 12 charts
Lymphoid

Lymphoma, Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell

NCT00505921 2011-11-16

Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma

M.D. Anderson Cancer Center

Phase 2 Terminated
27 enrolled 5 charts
Lymphoid

Lymphoma, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡